Project Start
1997-09-01
Project End
1998-08-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Nguyen, Holly M; Corey, Eva (2011) Methodology to investigate androgen-sensitive and castration-resistant human prostate cancer xenografts in preclinical setting. Methods Mol Biol 776:295-312
Roudier, Martine P; Morrissey, Colm; True, Lawrence D et al. (2008) Histopathological assessment of prostate cancer bone osteoblastic metastases. J Urol 180:1154-60
Pfitzenmaier, Jesco; Ellis, William J; Arfman, Edward W et al. (2006) Telomerase activity in disseminated prostate cancer cells. BJU Int 97:1309-13
Roudier, M P; True, L D; Vessella, R L et al. (2004) Metastatic conventional prostatic adenocarcinoma with diffuse chromogranin A and androgen receptor positivity. J Clin Pathol 57:321-3
Roudier, Martine P; Corey, Eva; True, Lawrence D et al. (2004) Histological, immunophenotypic and histomorphometric characterization of prostate cancer bone metastases. Cancer Treat Res 118:311-39
Brubaker, K D; Corey, E; Brown, L G et al. (2004) Bone morphogenetic protein signaling in prostate cancer cell lines. J Cell Biochem 91:151-60
Blaszczyk, Natalie; Masri, Bassam A; Mawji, Nasrin R et al. (2004) Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells. Clin Cancer Res 10:1860-9
Shariat, Shahrokh F; Roudier, Martine P; Wilcox, George E et al. (2003) Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes. Cancer Res 63:4662-70
Brubaker, Kristen D; Vessella, Robert L; Brown, Lisha G et al. (2003) Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function. Prostate 56:13-22
Corey, Eva; Quinn, Janna E; Vessella, Robert L (2003) A novel method of generating prostate cancer metastases from orthotopic implants. Prostate 56:110-4

Showing the most recent 10 out of 48 publications